Overview A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis Status: Active, not recruiting Trial end date: 2021-12-17 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy of guselkumab for the treatment of palmoplantar psoriasis. Phase: Phase 3 Details Lead Sponsor: Janssen-Cilag Ltd.